176 related articles for article (PubMed ID: 1578486)
1. Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G.
Zembower DE; Kam CM; Powers JC; Zalkow LH
J Med Chem; 1992 May; 35(9):1597-605. PubMed ID: 1578486
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective synthesis of peptidyl trifluoromethyl alcohols and ketones: inhibitory potency against human leucocyte elastase, cathepsin G, porcine pancreatic elastase and HIV-1 protease.
Amour A; Reboud-Ravaux M; de Rosny E; Abouabdellah A; Bégue JP; Bonnet-Delpon D; Le Gall M
J Pharm Pharmacol; 1998 Jun; 50(6):593-600. PubMed ID: 9680068
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin.
Baici A; Diczházi C; Neszmélyi A; Móczár E; Hornebeck W
Biochem Pharmacol; 1993 Nov; 46(9):1545-9. PubMed ID: 8240409
[TBL] [Abstract][Full Text] [Related]
4. Mechanism-based inhibition of human leukocyte elastase and cathepsin G by substituted dihydrouracils.
Groutas WC; Huang H; Epp JB; Venkataraman R; McClenahan JJ; Tagusagawa F
Biochim Biophys Acta; 1994 Nov; 1227(3):130-6. PubMed ID: 7986820
[TBL] [Abstract][Full Text] [Related]
5. Efficient inhibition of human leukocyte elastase and cathepsin G by saccharin derivatives.
Groutas WC; Houser-Archield N; Chong LS; Venkataraman R; Epp JB; Huang H; McClenahan JJ
J Med Chem; 1993 Oct; 36(21):3178-81. PubMed ID: 8230105
[TBL] [Abstract][Full Text] [Related]
6. Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one.
Groutas WC; Chong LS; Venkataraman R
Biochem Biophys Res Commun; 1993 Dec; 197(2):730-9. PubMed ID: 8267609
[TBL] [Abstract][Full Text] [Related]
7. Substituted 3-oxo-1,2,5-thiadiazolidine 1,1-dioxides: a new class of potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G.
Groutas WC; Kuang R; Venkataraman R
Biochem Biophys Res Commun; 1994 Jan; 198(1):341-9. PubMed ID: 8292039
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a trihexacontapeptide corresponding to the sequence 8-70 of eglin c and studies on the relationship between the structure and the inhibitory activity against human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
Okada Y; Tsuboi S; Tsuda Y; Nagamatsu Y; Yamamoto J
FEBS Lett; 1990 Oct; 272(1-2):113-6. PubMed ID: 2226822
[TBL] [Abstract][Full Text] [Related]
9. 6-Acylamino-2-1[(ethylsulfonyl)oxy]-1H-isoindole-1,3-diones mechanism-based inhibitors of human leukocyte elastase and cathepsin G: effect of chirality in the 6-acylamino substituent on inhibitory potency and selectivity.
Vagnoni LM; Gronostaj M; Kerrigan JE
Bioorg Med Chem; 2001 Mar; 9(3):637-45. PubMed ID: 11310598
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of human neutrophil elastase and cathepsin G by peptidyl 1,2-dicarbonyl derivatives.
Mehdi S; Angelastro MR; Burkhart JP; Koehl JR; Peet NP; Bey P
Biochem Biophys Res Commun; 1990 Jan; 166(2):595-600. PubMed ID: 2302225
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human neutrophil elastase and cathepsin G by a biphenyl disulfonic acid copolymer.
Janusz MJ; Hare M
Int J Immunopharmacol; 1994 Aug; 16(8):623-32. PubMed ID: 7989132
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of succinimide derivatives as potential mechanism-based inhibitors of human leukocyte elastase, cathepsin G and proteinase 3.
Groutas WC; Brubaker MJ; Chong LS; Venkataraman R; Huang H; Epp JB; Kuang R; Hoidal JR
Bioorg Med Chem; 1995 Apr; 3(4):375-81. PubMed ID: 8581420
[TBL] [Abstract][Full Text] [Related]
13. A new class of heterocyclic serine protease inhibitors. Inhibition of human leukocyte elastase, porcine pancreatic elastase, cathepsin G, and bovine chymotrypsin A alpha with substituted benzoxazinones, quinazolines, and anthranilates.
Teshima T; Griffin JC; Powers JC
J Biol Chem; 1982 May; 257(9):5085-91. PubMed ID: 7040392
[TBL] [Abstract][Full Text] [Related]
14. The kinetic mechanism of inhibition of human leukocyte elastase by MR889, a new cyclic thiolic compound.
Baici A; Pelloso R; Hörler D
Biochem Pharmacol; 1990 Mar; 39(5):919-24. PubMed ID: 2310417
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.
Renesto P; Balloy V; Kamimura T; Masuda K; Imaizumi A; Chignard M
Br J Pharmacol; 1993 Apr; 108(4):1100-6. PubMed ID: 8097952
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the human leukocyte proteinases elastase and cathepsin G with gold, silver and copper compounds.
Baici A; Camus A; Marsich N
Biochem Pharmacol; 1984 Jun; 33(12):1859-65. PubMed ID: 6428416
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human leukocyte elastase, cathepsin G, chymotrypsin A alpha, and porcine pancreatic elastase with substituted isobenzofuranones and benzopyrandiones.
Hemmi K; Harper JW; Powers JC
Biochemistry; 1985 Apr; 24(8):1841-8. PubMed ID: 3848330
[TBL] [Abstract][Full Text] [Related]
18. Isoxazoline derivatives as potential inhibitors of the proteolytic enzymes human leukocyte elastase, cathepsin G and proteinase 3: a structure-activity relationship study.
Groutas WC; Venkataraman R; Chong LS; Yoder JE; Epp JB; Stanga MA; Kim EH
Bioorg Med Chem; 1995 Feb; 3(2):125-8. PubMed ID: 7796046
[No Abstract] [Full Text] [Related]
19. Inhibition of human leukocyte elastase (HLE) by N-substituted peptidyl trifluoromethyl ketones.
Skiles JW; Fuchs V; Miao C; Sorcek R; Grozinger KG; Mauldin SC; Vitous J; Mui PW; Jacober S; Chow G
J Med Chem; 1992 Feb; 35(4):641-62. PubMed ID: 1542092
[TBL] [Abstract][Full Text] [Related]
20. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
Janusz MJ; Doherty NS
J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
